G

G
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.291B ▲ | $278.014M ▲ | $145.831M ▲ | 11.294% ▲ | $0.84 ▲ | $229.412M ▲ |
| Q2-2025 | $1.254B ▲ | $270.666M ▲ | $132.716M ▲ | 10.58% ▼ | $0.76 ▲ | $216.271M ▲ |
| Q1-2025 | $1.215B ▼ | $245.292M ▼ | $130.853M ▼ | 10.77% ▼ | $0.75 ▼ | $214.136M ▼ |
| Q4-2024 | $1.249B ▲ | $255.598M ▲ | $141.915M ▲ | 11.365% ▲ | $0.8 ▲ | $227.614M ▲ |
| Q3-2024 | $1.211B | $249.788M | $132.818M | 10.968% | $0.75 | $221.98M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $740.763M ▲ | $5.364B ▲ | $2.82B ▲ | $2.545B ▼ |
| Q2-2025 | $663.26M ▲ | $5.308B ▲ | $2.721B ▲ | $2.587B ▲ |
| Q1-2025 | $561.615M ▼ | $4.895B ▼ | $2.442B ▼ | $2.453B ▲ |
| Q4-2024 | $671.605M ▼ | $4.987B ▼ | $2.598B ▼ | $2.39B ▼ |
| Q3-2024 | $1.023B | $5.326B | $2.931B | $2.395B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $145.831M ▲ | $308.36M ▲ | $-19.216M ▲ | $-208.957M ▼ | $77.503M ▼ | $292.017M ▲ |
| Q2-2025 | $132.716M ▲ | $177.365M ▲ | $-105.199M ▼ | $18.871M ▲ | $101.645M ▲ | $152.757M ▲ |
| Q1-2025 | $130.853M ▼ | $40.436M ▼ | $779K ▲ | $-125.544M ▲ | $-86.631M ▲ | $17.856M ▼ |
| Q4-2024 | $141.915M ▲ | $203.247M ▼ | $-41.251M ▼ | $-517.426M ▼ | $-374.401M ▼ | $182.848M ▼ |
| Q3-2024 | $132.818M | $228.464M | $-20.288M | $-109.736M | $108.476M | $209.951M |
Revenue by Products
| Product | Q4-2022 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Consumer And Healthcare | $1.22Bn ▲ | $420.00M ▼ | $430.00M ▲ | $430.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Genpact combines steady top‑line growth, improving operating performance, and dependable cash generation with a balance sheet that appears generally sound, though not without leverage. Its long‑standing process expertise and global delivery model give it a durable, if contested, place in the IT services ecosystem. The company is betting heavily on AI and automation to move up the value chain and strengthen its competitive moat. The story from here hinges less on financial stability—which looks reasonable—and more on how effectively Genpact can turn its AI strategy and innovation pipeline into sustained, higher‑quality growth in a very competitive market.
NEWS
November 13, 2025 · 4:05 PM UTC
Genpact Limited Announces Pricing of 4.950% Senior Notes due 2030 by Genpact UK Finco plc and Genpact USA, Inc.
Read more
November 13, 2025 · 8:05 AM UTC
Genpact Recognized in Salesforce 2025 Partner Innovation Awards
Read more
November 10, 2025 · 8:05 AM UTC
Genpact Named the Celonis® Game Changer Global Partner of the Year for 2025
Read more
November 6, 2025 · 4:05 PM UTC
Genpact Reports Third Quarter 2025 Results
Read more
October 29, 2025 · 8:05 AM UTC
Genpact Recognized by Forbes as One of the World's Best Employers 2025
Read more
About Genpact Limited
https://www.genpact.comGenpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.291B ▲ | $278.014M ▲ | $145.831M ▲ | 11.294% ▲ | $0.84 ▲ | $229.412M ▲ |
| Q2-2025 | $1.254B ▲ | $270.666M ▲ | $132.716M ▲ | 10.58% ▼ | $0.76 ▲ | $216.271M ▲ |
| Q1-2025 | $1.215B ▼ | $245.292M ▼ | $130.853M ▼ | 10.77% ▼ | $0.75 ▼ | $214.136M ▼ |
| Q4-2024 | $1.249B ▲ | $255.598M ▲ | $141.915M ▲ | 11.365% ▲ | $0.8 ▲ | $227.614M ▲ |
| Q3-2024 | $1.211B | $249.788M | $132.818M | 10.968% | $0.75 | $221.98M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $740.763M ▲ | $5.364B ▲ | $2.82B ▲ | $2.545B ▼ |
| Q2-2025 | $663.26M ▲ | $5.308B ▲ | $2.721B ▲ | $2.587B ▲ |
| Q1-2025 | $561.615M ▼ | $4.895B ▼ | $2.442B ▼ | $2.453B ▲ |
| Q4-2024 | $671.605M ▼ | $4.987B ▼ | $2.598B ▼ | $2.39B ▼ |
| Q3-2024 | $1.023B | $5.326B | $2.931B | $2.395B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $145.831M ▲ | $308.36M ▲ | $-19.216M ▲ | $-208.957M ▼ | $77.503M ▼ | $292.017M ▲ |
| Q2-2025 | $132.716M ▲ | $177.365M ▲ | $-105.199M ▼ | $18.871M ▲ | $101.645M ▲ | $152.757M ▲ |
| Q1-2025 | $130.853M ▼ | $40.436M ▼ | $779K ▲ | $-125.544M ▲ | $-86.631M ▲ | $17.856M ▼ |
| Q4-2024 | $141.915M ▲ | $203.247M ▼ | $-41.251M ▼ | $-517.426M ▼ | $-374.401M ▼ | $182.848M ▼ |
| Q3-2024 | $132.818M | $228.464M | $-20.288M | $-109.736M | $108.476M | $209.951M |
Revenue by Products
| Product | Q4-2022 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Consumer And Healthcare | $1.22Bn ▲ | $420.00M ▼ | $430.00M ▲ | $430.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Genpact combines steady top‑line growth, improving operating performance, and dependable cash generation with a balance sheet that appears generally sound, though not without leverage. Its long‑standing process expertise and global delivery model give it a durable, if contested, place in the IT services ecosystem. The company is betting heavily on AI and automation to move up the value chain and strengthen its competitive moat. The story from here hinges less on financial stability—which looks reasonable—and more on how effectively Genpact can turn its AI strategy and innovation pipeline into sustained, higher‑quality growth in a very competitive market.
NEWS
November 13, 2025 · 4:05 PM UTC
Genpact Limited Announces Pricing of 4.950% Senior Notes due 2030 by Genpact UK Finco plc and Genpact USA, Inc.
Read more
November 13, 2025 · 8:05 AM UTC
Genpact Recognized in Salesforce 2025 Partner Innovation Awards
Read more
November 10, 2025 · 8:05 AM UTC
Genpact Named the Celonis® Game Changer Global Partner of the Year for 2025
Read more
November 6, 2025 · 4:05 PM UTC
Genpact Reports Third Quarter 2025 Results
Read more
October 29, 2025 · 8:05 AM UTC
Genpact Recognized by Forbes as One of the World's Best Employers 2025
Read more

CEO
Balkrishan Kalra
Compensation Summary
(Year 2024)

CEO
Balkrishan Kalra
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK INC.
19.927M Shares
$877.988M

FMR LLC
18.426M Shares
$811.866M

VANGUARD GROUP INC
16.507M Shares
$727.308M

BLACKROCK, INC.
16.476M Shares
$725.925M

NALANDA INDIA EQUITY FUND LTD
12.687M Shares
$558.987M

VICTORY CAPITAL MANAGEMENT INC
5.324M Shares
$234.562M

STATE STREET CORP
5.135M Shares
$226.267M

GEODE CAPITAL MANAGEMENT, LLC
4.222M Shares
$186.032M

DIMENSIONAL FUND ADVISORS LP
3.978M Shares
$175.28M

JPMORGAN CHASE & CO
3.762M Shares
$165.772M

FIDUCIARY MANAGEMENT INC /WI/
3.634M Shares
$160.102M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
3.528M Shares
$155.456M

AQR CAPITAL MANAGEMENT LLC
3.443M Shares
$151.719M

FRANKLIN RESOURCES INC
3.379M Shares
$148.887M

TANDEM INVESTMENT ADVISORS, INC.
2.936M Shares
$129.369M

MORGAN STANLEY
2.76M Shares
$121.603M

SUMITOMO MITSUI TRUST HOLDINGS, INC.
2.585M Shares
$113.878M

NORDEA INVESTMENT MANAGEMENT AB
2.518M Shares
$110.925M

CITADEL ADVISORS LLC
2.243M Shares
$98.834M

FIL LTD
2.24M Shares
$98.711M
Summary
Only Showing The Top 20







